Abundant evidence has indicated that the prognosis of cutaneous melanoma (CM) patients
is highly complicated by the tumour immune microenvironment. We retrieved the clinical …

We aimed to fully understand the landscape of the skin cutaneous melanoma (SKCM)
microenvironment and develop an immune prognostic signature that can predict the …

Background Skin cutaneous melanoma (SKCM) is the most frequently encountered tumor of
the skin. Immunotherapy has opened a new horizon in melanoma treatment. We aimed to …

Background Cutaneous melanoma (CM) is one of the most aggressive cancers with highly
metastatic ability. To make things worse, there are limited effective therapies to treat …

Melanoma is the most invasive type of skin cancer, in which the immune system plays a vital
role. In this study, we aimed to establish a prognostic prediction nomogram for melanoma …

Cutaneous melanoma is one of the most aggressive cancers characterized by increasing
incidence and mortality. In recent years, the emergence of immunotherapy has greatly …

Melanoma is a life-threatening form of skin cancer with an elevated risk of metastasis and
high mortality rates. The prognosis and clinical outcomes of cancer immunotherapy in …

Cutaneous melanoma (CM) is a malignant and aggressive skin cancer that is the leading
cause of skin cancer-related deaths. Increasing evidence shows that immunity plays a vital …

In this study, we aimed to identify an immune-related signature for predicting prognosis in
cutaneous melanoma (CM). Sample data from The Cancer Genome Atlas (TCGA; n= 460) …

Cutaneous melanoma (CM) is the leading cause of skin cancer deaths and is typically
diagnosed at an advanced stage, resulting in a poor prognosis. The tumor …